{
  "schemaVersion": 1,
  "organisationId": "O-967451f83b36497c82c1ae74a3179a9b",
  "slug": "avantor-inc",
  "name": "Avantor, Inc.",
  "updatedAt": "2026-10-02T13:09:07.428062Z",
  "sections": [
    {
      "type": "OVERVIEW",
      "text": "Avantor, Inc. is a global life-sciences and laboratory-products company supplying mission-critical products and services to the life sciences and advanced technology industries. Its offerings include laboratory and bioprocess products, equipment, chemicals, consumables, distribution, and related services; its 2026 reporting identifies Bioscience & Medtech Products and VWR Distribution & Services as its two business segments. [P144151384][P144151418][P144341101] The company states its mission as “We set science in motion to create a better world.” [https://corporate.avantorsciences.com/us/en/about/mission-vision-values]\n\nAvantor reports that its portfolio serves more than 300,000 customer locations in 180 countries, and its website describes a workforce of more than 13,500 associates worldwide. [P144151418][https://corporate.avantorsciences.com/us/en/about/people-culture] For the fiscal year ended December 31, 2025, net sales were approximately $6.55 billion. [T10161909] The company traces its origins to 1904, when John Townsend (J.T.) Baker founded the business. [https://corporate.avantorsciences.com/us/en/about/who-we-are]\n[P144151384][P144151418][P144341101][https://corporate.avantorsciences.com/us/en/about/mission-vision-values][https://corporate.avantorsciences.com/us/en/about/people-culture][T10161909][https://corporate.avantorsciences.com/us/en/about/who-we-are][https://corporate.avantorsciences.com/us/en/about/mission-vision-values][https://corporate.avantorsciences.com/us/en/about/people-culture][https://corporate.avantorsciences.com/us/en/about/who-we-are]",
      "updatedAt": "2026-10-02T13:09:07.428062Z"
    },
    {
      "type": "PRODUCTS",
      "text": "Avantor supplies laboratory materials and consumables, including high-purity chemicals and reagents, specialized formulated silicones, customized excipients, single-use assemblies, chromatography resins and columns, analytical sample-preparation kits, and education, microbiology, and clinical-trial kits. Its equipment and instrumentation offerings include filtration and virus-inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, peristaltic pumps, and biological safety cabinets. [P56653429] [P73505746] [P121757867] Product brands include J.T.Baker for high-purity chemicals, Masterflex for fluid handling, and NuSil for high-purity silicones, including materials for human implants. [P115732939] [P55860074] [https://corporate.avantorsciences.com/us/en/about/brands] [https://corporate.avantorsciences.com/us/en/brands/j-t-baker]\n\nServices include onsite laboratory and production support, equipment services, procurement and sourcing, and biopharmaceutical material scale-up and development. Onsite support can cover inventory and chemical management, solution preparation, replenishment, sample handling, and waste management. [P118974754] [https://www.avantorsciences.com/ie/en/services/general-lab] [https://www.avantorsciences.com/jp/en/services/equipment/additional-laboratory-equipment-and-instruments] For the six months ended June 30, 2026, VWR Distribution & Services accounted for $2,390.5 million, approximately 73.0% of net sales, while Bioscience & Medtech Products accounted for $883.2 million, approximately 27.0%; percentages are calculated from reported segment sales. [T16517127]\n[P56653429][P73505746][P121757867][P115732939][P55860074][https://corporate.avantorsciences.com/us/en/about/brands][https://corporate.avantorsciences.com/us/en/brands/j-t-baker][P118974754][https://www.avantorsciences.com/ie/en/services/general-lab][https://www.avantorsciences.com/jp/en/services/equipment/additional-laboratory-equipment-and-instruments][T16517127][T16517127][https://corporate.avantorsciences.com/us/en/about/brands][https://corporate.avantorsciences.com/us/en/brands/j-t-baker][https://www.avantorsciences.com/ie/en/services/general-lab][https://www.avantorsciences.com/jp/en/services/equipment/additional-laboratory-equipment-and-instruments]",
      "updatedAt": "2026-10-02T13:09:07.428062Z"
    },
    {
      "type": "GEOGRAPHY",
      "text": "In FY2025, Avantor reported net sales of $6,552.2 million, of which $3,279.7 million (50.1%) came from the United States and $3,272.5 million (49.9%) from all other countries. Its filing reports non-U.S. sales in aggregate rather than by individual country or named region. [T9493420]\n\nAvantor describes a manufacturing footprint of more than 40 facilities across North America, Europe, and AMEA (Asia, the Middle East and Africa), alongside 15 innovation centers and a global distribution-center network. [P73591745] It serves more than 300,000 customer locations in approximately 180 countries. [P100723417] The company’s careers site describes more than 200 locations in 30 countries; its corporate history page reports more than 14,500 associates, without a geographic employee breakdown. [https://careers.avantorsciences.com/global/en/home] [https://corporate.avantorsciences.com/us/en/about/history]\n[T9493420][T9493420][P73591745][P100723417][https://careers.avantorsciences.com/global/en/home][https://corporate.avantorsciences.com/us/en/about/history]",
      "updatedAt": "2026-10-02T13:09:07.428062Z"
    },
    {
      "type": "SEGMENTS",
      "text": "Effective January 1, 2026, Avantor reports two segments: **Bioscience & Medtech Products** and **VWR Distribution & Services**. Bioscience & Medtech Products includes products such as process chemicals, fluid handling products, and NuSil materials; VWR Distribution & Services centers on distribution of laboratory consumables, equipment, and instrumentation, along with value-added services. [P65860237][P44276882][P36580095][P5218533][P55860074]\n\nOn the recast FY2025 basis, Bioscience & Medtech Products generated $4,730.2 million, approximately **72%** of consolidated net sales, while VWR Distribution & Services generated $1,822.0 million, approximately **28%**. [P10880020][P105561744] Avantor’s FY2025 Form 10-K used the prior segment names: Laboratory Solutions ($4,399.7 million, approximately **67%**) and Bioscience Production ($2,152.5 million, approximately **33%**) of FY2025 net sales. [P86527394][P50858155][P105561744]\n[P65860237][P44276882][P36580095][P5218533][P55860074][P10880020][P105561744][P86527394][P50858155]",
      "updatedAt": "2026-10-02T13:09:07.428062Z"
    },
    {
      "type": "HISTORY",
      "text": "Avantor’s historical roots include the John Taylor Company, founded in 1852, and J.T. Baker Chemical Company, founded by John Townsend in 1904 to produce high-purity chemicals. [https://corporate.avantorsciences.com/us/en/about/history] In 2010, New Mountain Capital acquired the business then known as Mallinckrodt Baker, Inc. [P66974868]\n\nA major turning point came on November 21, 2017, when Avantor completed its acquisition of VWR, expanding its laboratory products and distribution business. [https://www.newmountaincapital.com/avantor-completes-acquisition-of-vwr/] Avantor closed its initial public offering on May 21, 2019, and began trading on the New York Stock Exchange under the symbol AVTR. [https://news.avantorsciences.com/2019-05-21-Avantor-R-Announces-Closing-of-Initial-Public-Offering-and-Concurrent-Offering-of-Mandatory-Convertible-Preferred-Stock-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares]\n\nIn 2021, the company completed acquisitions of Ritter GmbH and affiliates, followed by Masterflex, broadening its offerings in laboratory and bioprocessing products. [https://news.avantorsciences.com/2021-06-10-Avantor-R-Completes-Acquisition-of-Ritter-GmbH-and-its-Affiliates] [https://news.avantorsciences.com/2021-11-01-Avantor-R-Completes-Acquisition-of-Masterflex-R] Avantor sold its Clinical Services business in October 2024. [P38711420] Emmanuel Ligner became President and CEO in August 2025, succeeding Michael Stubblefield. [P68808949]\n[P66974868][P38711420][P68808949][https://corporate.avantorsciences.com/us/en/about/history][https://www.newmountaincapital.com/avantor-completes-acquisition-of-vwr/][https://news.avantorsciences.com/2019-05-21-Avantor-R-Announces-Closing-of-Initial-Public-Offering-and-Concurrent-Offering-of-Mandatory-Convertible-Preferred-Stock-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares][https://news.avantorsciences.com/2021-06-10-Avantor-R-Completes-Acquisition-of-Ritter-GmbH-and-its-Affiliates][https://news.avantorsciences.com/2021-11-01-Avantor-R-Completes-Acquisition-of-Masterflex-R]",
      "updatedAt": "2026-10-02T13:09:07.428062Z"
    }
  ],
  "sources": [
    {
      "id": "P144151384",
      "href": "https://app.finbar.com/go?id=P144151384",
      "label": "Avantor, Inc. — Press release (2026 Q 2)",
      "documentId": "D-79d7888cd2834f289f10ad14770425b3"
    },
    {
      "id": "P144151418",
      "href": "https://app.finbar.com/go?id=P144151418",
      "label": "Avantor, Inc. — Press release (2026 Q 2)",
      "documentId": "D-79d7888cd2834f289f10ad14770425b3"
    },
    {
      "id": "P144341101",
      "href": "https://app.finbar.com/go?id=P144341101",
      "label": "Avantor, Inc. — Full financial report (2026 Q 2)",
      "documentId": "D-0c8df515fe2348719007fc157c1b19ef"
    },
    {
      "id": "https://corporate.avantorsciences.com/us/en/about/mission-vision-values",
      "href": "https://corporate.avantorsciences.com/us/en/about/mission-vision-values",
      "label": "corporate.avantorsciences.com"
    },
    {
      "id": "https://corporate.avantorsciences.com/us/en/about/people-culture",
      "href": "https://corporate.avantorsciences.com/us/en/about/people-culture",
      "label": "corporate.avantorsciences.com"
    },
    {
      "id": "T10161909",
      "href": "https://app.finbar.com/go?id=T10161909",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "https://corporate.avantorsciences.com/us/en/about/who-we-are",
      "href": "https://corporate.avantorsciences.com/us/en/about/who-we-are",
      "label": "corporate.avantorsciences.com"
    },
    {
      "id": "P56653429",
      "href": "https://app.finbar.com/go?id=P56653429",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P73505746",
      "href": "https://app.finbar.com/go?id=P73505746",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P121757867",
      "href": "https://app.finbar.com/go?id=P121757867",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P115732939",
      "href": "https://app.finbar.com/go?id=P115732939",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P55860074",
      "href": "https://app.finbar.com/go?id=P55860074",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "https://corporate.avantorsciences.com/us/en/about/brands",
      "href": "https://corporate.avantorsciences.com/us/en/about/brands",
      "label": "corporate.avantorsciences.com"
    },
    {
      "id": "https://corporate.avantorsciences.com/us/en/brands/j-t-baker",
      "href": "https://corporate.avantorsciences.com/us/en/brands/j-t-baker",
      "label": "corporate.avantorsciences.com"
    },
    {
      "id": "P118974754",
      "href": "https://app.finbar.com/go?id=P118974754",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "https://www.avantorsciences.com/ie/en/services/general-lab",
      "href": "https://www.avantorsciences.com/ie/en/services/general-lab",
      "label": "www.avantorsciences.com"
    },
    {
      "id": "https://www.avantorsciences.com/jp/en/services/equipment/additional-laboratory-equipment-and-instruments",
      "href": "https://www.avantorsciences.com/jp/en/services/equipment/additional-laboratory-equipment-and-instruments",
      "label": "www.avantorsciences.com"
    },
    {
      "id": "T16517127",
      "href": "https://app.finbar.com/go?id=T16517127",
      "label": "Avantor, Inc. — Full financial report (2026 Q 2)",
      "documentId": "D-0c8df515fe2348719007fc157c1b19ef"
    },
    {
      "id": "T9493420",
      "href": "https://app.finbar.com/go?id=T9493420",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P73591745",
      "href": "https://app.finbar.com/go?id=P73591745",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P100723417",
      "href": "https://app.finbar.com/go?id=P100723417",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "https://careers.avantorsciences.com/global/en/home",
      "href": "https://careers.avantorsciences.com/global/en/home",
      "label": "careers.avantorsciences.com"
    },
    {
      "id": "https://corporate.avantorsciences.com/us/en/about/history",
      "href": "https://corporate.avantorsciences.com/us/en/about/history",
      "label": "corporate.avantorsciences.com"
    },
    {
      "id": "P65860237",
      "href": "https://app.finbar.com/go?id=P65860237",
      "label": "Avantor, Inc. — Full financial report (2026 Q 1)",
      "documentId": "D-85a6f5b0a8db4d83aa2af16371c0b526"
    },
    {
      "id": "P44276882",
      "href": "https://app.finbar.com/go?id=P44276882",
      "label": "Avantor, Inc. — Full financial report (2026 Q 1)",
      "documentId": "D-85a6f5b0a8db4d83aa2af16371c0b526"
    },
    {
      "id": "P36580095",
      "href": "https://app.finbar.com/go?id=P36580095",
      "label": "Avantor, Inc. — Full financial report (2026 Q 1)",
      "documentId": "D-85a6f5b0a8db4d83aa2af16371c0b526"
    },
    {
      "id": "P5218533",
      "href": "https://app.finbar.com/go?id=P5218533",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P10880020",
      "href": "https://app.finbar.com/go?id=P10880020",
      "label": "Avantor, Inc. — Additional data (2026 Q 1), p12",
      "documentId": "D-3030075b68d143a68c8ab9c51664880f",
      "page": 12
    },
    {
      "id": "P105561744",
      "href": "https://app.finbar.com/go?id=P105561744",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P86527394",
      "href": "https://app.finbar.com/go?id=P86527394",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P50858155",
      "href": "https://app.finbar.com/go?id=P50858155",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P66974868",
      "href": "https://app.finbar.com/go?id=P66974868",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "https://www.newmountaincapital.com/avantor-completes-acquisition-of-vwr/",
      "href": "https://www.newmountaincapital.com/avantor-completes-acquisition-of-vwr/",
      "label": "www.newmountaincapital.com"
    },
    {
      "id": "https://news.avantorsciences.com/2019-05-21-Avantor-R-Announces-Closing-of-Initial-Public-Offering-and-Concurrent-Offering-of-Mandatory-Convertible-Preferred-Stock-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares",
      "href": "https://news.avantorsciences.com/2019-05-21-Avantor-R-Announces-Closing-of-Initial-Public-Offering-and-Concurrent-Offering-of-Mandatory-Convertible-Preferred-Stock-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares",
      "label": "news.avantorsciences.com"
    },
    {
      "id": "https://news.avantorsciences.com/2021-06-10-Avantor-R-Completes-Acquisition-of-Ritter-GmbH-and-its-Affiliates",
      "href": "https://news.avantorsciences.com/2021-06-10-Avantor-R-Completes-Acquisition-of-Ritter-GmbH-and-its-Affiliates",
      "label": "news.avantorsciences.com"
    },
    {
      "id": "https://news.avantorsciences.com/2021-11-01-Avantor-R-Completes-Acquisition-of-Masterflex-R",
      "href": "https://news.avantorsciences.com/2021-11-01-Avantor-R-Completes-Acquisition-of-Masterflex-R",
      "label": "news.avantorsciences.com"
    },
    {
      "id": "P38711420",
      "href": "https://app.finbar.com/go?id=P38711420",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    },
    {
      "id": "P68808949",
      "href": "https://app.finbar.com/go?id=P68808949",
      "label": "Avantor, Inc. — Full financial report (2025 Y)",
      "documentId": "D-ef764061ab4e4396b29b37e4e4e21c1e"
    }
  ]
}